CATX – perspective therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Perspective Therapeutics (NASDAQ:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $14.00 price target on the stock.
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference
Form SCHEDULE 13G Perspective Therapeutics Filed by: Commodore Capital LP
Form SCHEDULE 13G Perspective Therapeutics Filed by: TCG Crossover GP II, LLC
Form SCHEDULE 13G Perspective Therapeutics Filed by: Qatar Investment Authority
Form 8-K Perspective Therapeutics For: Feb 02
Form 424B5 Perspective Therapeutics
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.